Offerings // Mereo BioPharma Group plc

MREO offering history

Every offering-related filing in Mereo BioPharma Group plc’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 437 filings back to Dec 1, 2017.

Last executed offering

Jun 14, 2024

424B5 — priced deal (shares or notes)

Last registration (announced)

Nov 25, 2024

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Dec 4, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 4, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 25, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 14, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 22, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 15, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 30, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 27, 2021	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Sep 7, 2021	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Aug 5, 2021	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Feb 10, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 9, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 23, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 21, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 6, 2020	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Jul 10, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 9, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 6, 2020	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Mar 19, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 12, 2020	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Mar 6, 2020	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Feb 18, 2020	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet
Mar 20, 2019	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 20, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 20, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 21, 2019	RW →	WITHDRAWN	Registration withdrawn
Apr 9, 2018	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Mar 23, 2018	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet

MREO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full MREO workspace →

MREO offering FAQ

When did MREO last execute an offering?

Per SEC filings, Mereo BioPharma Group plc's most recent priced offering document is a 424B5 filed 2024-06-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did MREO last announce or register an offering?

The most recent registration is a S-3 filed 2024-11-25. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.